Precision Biosciences Stock Price on October 23, 2024
| DTIL Stock | USD 7.26 0.76 11.69% |
Below is the normalized historical share price chart for Precision BioSciences extending back to March 28, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Precision BioSciences stands at 7.26, as last reported on the 25th of November, with the highest price reaching 7.46 and the lowest price hitting 6.51 during the day.
If you're considering investing in Precision Stock, it is important to understand the factors that can impact its price. Precision BioSciences maintains Sharpe Ratio (i.e., Efficiency) of -0.12, which implies the firm had a -0.12% return per unit of risk over the last 3 months. Precision BioSciences exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Precision BioSciences' Coefficient Of Variation of (831.68), variance of 10.51, and Risk Adjusted Performance of (0.08) to confirm the risk estimate we provide.
At this time, Precision BioSciences' Liabilities And Stockholders Equity is quite stable compared to the past year. Capital Stock is expected to rise to 1,208 this year, although the value of Total Stockholder Equity will most likely fall to about 17.9 M. . At this time, Precision BioSciences' Price Book Value Ratio is quite stable compared to the past year. Price Earnings To Growth Ratio is expected to rise to 0.01 this year, although the value of Price Earnings Ratio will most likely fall to (0.72). Precision Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 28th of March 2019 | 200 Day MA 10.5978 | 50 Day MA 8.6736 | Beta 1.693 |
Precision |
Sharpe Ratio = -0.123
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DTIL |
Estimated Market Risk
| 3.26 actual daily | 29 71% of assets are more volatile |
Expected Return
| -0.4 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.12 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Precision BioSciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Precision BioSciences by adding Precision BioSciences to a well-diversified portfolio.
Price Book 0.8586 | Enterprise Value Ebitda (0.27) | Price Sales 0.7416 | Shares Float 6.2 M | Wall Street Target Price 35.75 |
Related Headline
Lumos Pharma Headline on 23rd of October 2024
Lumos Pharma Enters into Definitive Merger Agreement with Do... by finance.yahoo.com
Lumos Pharma and the FDA Align on Final Design for Global, Double-blinded, Placebo-Controlled Phase 3 Trial Evaluating Oral LUM-201 in PGHDAUSTIN, Texas, Oct. 23, 2024 -- Lumos Pharma, Inc. , a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that the Company has entered into a definitive merger agreement, dated October 22, 2024 whereby Double Point Ventures
Precision BioSciences Valuation on October 23, 2024
It is possible to determine the worth of Precision BioSciences on a given historical date. On October 23, 2024 Precision was worth 8.73 at the beginning of the trading date compared to the closed value of 8.55. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Precision BioSciences stock. Still, in general, we apply an absolute valuation method to find Precision BioSciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Precision BioSciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Precision BioSciences' related companies.
| Open | High | Low | Close | Volume | |
| 8.74 | 9.05 | 8.63 | 8.78 | 50,116 | |
10/23/2024 | 8.73 | 8.81 | 8.48 | 8.55 | 49,202 |
| 8.52 | 9.00 | 8.41 | 8.48 | 85,702 |
| Backtest Precision BioSciences | | | Precision BioSciences History | | | Precision BioSciences Valuation | Previous | Next |
Precision BioSciences Trading Date Momentum on October 23, 2024
| On October 24 2024 Precision BioSciences was traded for 8.48 at the closing time. The top price for the day was 9.00 and the lowest listed price was 8.41 . The trading volume for the day was 85.7 K. The trading history from October 24, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.82% . The trading delta at closing time against the current closing price is 0.70% . |
Precision BioSciences Fundamentals Correlations and Trends
By evaluating Precision BioSciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Precision BioSciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Precision financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Precision BioSciences Stock history
Precision BioSciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Precision is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Precision BioSciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Precision BioSciences stock prices may prove useful in developing a viable investing in Precision BioSciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 3.8 M | 3.1 M | |
| Net Loss | -100.5 M | -95.4 M |
Precision BioSciences Quarterly Net Working Capital |
|
Precision BioSciences Stock Technical Analysis
Precision BioSciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Precision BioSciences Period Price Range
Low | November 25, 2024
| High |
0.00 | 0.00 |
Precision BioSciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Precision BioSciences November 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Precision BioSciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Precision BioSciences shares will generate the highest return on investment. By undertsting and applying Precision BioSciences stock market strength indicators, traders can identify Precision BioSciences entry and exit signals to maximize returns
Precision BioSciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Precision BioSciences' price direction in advance. Along with the technical and fundamental analysis of Precision Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Precision to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.49) | |||
| Total Risk Alpha | (0.91) | |||
| Treynor Ratio | (0.53) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Precision BioSciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Precision Stock please use our How to buy in Precision Stock guide.You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Precision BioSciences. If investors know Precision will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Precision BioSciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 0.4 | Revenue Per Share 12.872 | Quarterly Revenue Growth (0.96) | Return On Assets (0.06) | Return On Equity 0.2444 |
The market value of Precision BioSciences is measured differently than its book value, which is the value of Precision that is recorded on the company's balance sheet. Investors also form their own opinion of Precision BioSciences' value that differs from its market value or its book value, called intrinsic value, which is Precision BioSciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Precision BioSciences' market value can be influenced by many factors that don't directly affect Precision BioSciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Precision BioSciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Precision BioSciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Precision BioSciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.